BioSpace News Archive

Myriad Genetics, Inc. announced that the National Comprehensive Cancer Network updated its professional guidelines for prostate cancer to recommend biomarker-based testing for men with unfavorable intermediate and high-risk disease.

Graybug Vision, Inc., a clinical stage biopharmaceutical company focused on developing transformative medicines to treat diseases of the retina and optic nerve, announced the early closing of enrollment in its ALTISSIMO trial.

Further expansion of HORAMA gene therapy portfolio to treat Inherited Retinal Dystrophies to lead to second clinical program by 2023

Vantage Galan 3T the First System in the MR Portfolio with Access to Advanced intelligent Clear-IQ Engine (AiCE)

SpringWorks Therapeutics, Inc. announced that the United States Patent and Trademark Office has issued U.S. Patent No. 10,590,087, directed to nirogacestat, the Company’s lead product candidate in development for patients with desmoid tumors and as a combination therapy for patients with multiple myeloma.

First Treatments at Munich Hospital Leverage MRIdian’s Precision for High-Dose Delivery and Adaptive Therapy Capabilities

Encompass Health Corp. announced its plans to build a freestanding, 40-bed inpatient rehabilitation hospital in a suburb of Waco, Texas.

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that it will present information on the edasalonexent program in Phase 3 development for the treatment of Duchenne muscular dystrophy (DMD) during the Muscular Dystrophy Association (MDA) Virtual Clinical Trials Session on Tuesday, March 24, 2020.

Inspirational Stories from Patients, Survivors, and Supporters Raise Awareness About the Broad Impact of Prostate Cancer on Millions Across the U.S.

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration issued an advisory on its dry eye syndrome Phase 3 clinical trial. To access the advisory, go to the following link: http://www.regenerx.com/2020-03-18-Ma